Highly pathogenic avian influenza A/H5N1 virus remains a potential pandemic threat, and it is essential to continue vaccine development against this subtype. A local mucosal immune response in the upper respiratory tract may stop influenza transmission. It is therefore important to develop effective intranasal pandemic influenza vaccines that induce mucosal immunity at the site of viral entry.

Svindland, S.C., Pedersen, G.K., Pathirana, R.D., Bredholt, G., Nøstbakken, J.K., Jul-Larsen, Å., et al. (2013). A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine. INFLUENZA AND OTHER RESPIRATORY VIRUSES, 7(6), 1181-1193 [10.1111/irv.12056].

A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine

Montomoli, Emanuele;
2013-01-01

Abstract

Highly pathogenic avian influenza A/H5N1 virus remains a potential pandemic threat, and it is essential to continue vaccine development against this subtype. A local mucosal immune response in the upper respiratory tract may stop influenza transmission. It is therefore important to develop effective intranasal pandemic influenza vaccines that induce mucosal immunity at the site of viral entry.
2013
Svindland, S.C., Pedersen, G.K., Pathirana, R.D., Bredholt, G., Nøstbakken, J.K., Jul-Larsen, Å., et al. (2013). A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine. INFLUENZA AND OTHER RESPIRATORY VIRUSES, 7(6), 1181-1193 [10.1111/irv.12056].
File in questo prodotto:
File Dimensione Formato  
038-2012_INFLUENZA-Svindland.pdf

accesso aperto

Licenza: Creative commons
Dimensione 660.58 kB
Formato Adobe PDF
660.58 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/976228
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo